4 results
8-K
EX-99.1
DMAC
DiaMedica Therapeutics Inc.
26 Jun 24
DiaMedica Therapeutics Announces $11.8 Million
8:16am
-101 – Protection of Minority Security Holders in Special Transactions (“MI 61-101”) of the Canadian Securities Administrators. The private placement … will be exempt from the valuation and the minority shareholder approval requirements of MI 61-101 under the exemptions contained in section 5.5
8-K
EX-99.1
DMAC
DiaMedica Therapeutics Inc.
21 Jun 23
DiaMedica Therapeutics Announces $37.5 Million Private Placement
8:42am
, the private placement constitutes a "related party transaction" as such term is defined in Multilateral Instrument 61-101 – Protection of Minority … the valuation and the minority shareholder approval requirements of MI 61-101 under the exemptions contained in section 5.5(a) and 5.7(1)(a), respectively
20FR12B/A
EX-4.7
DMAC
DiaMedica Therapeutics Inc.
11 Mar 14
Initial registration of securities (foreign private issuers) (amended)
12:00am
the Transaction), including any minority shareholder approvals, required by the TSXV (or TSXV policies) and Multilateral Instrument 61-101 (“MI 61-101
- Prev
- 1
- Next